Omega-3 fatty acid deficient male rats exhibit abnormal behavioral activation in the forced swim test following chronic fluoxetine treatment: Association with altered 5-HT1A and alpha2A adrenergic receptor expression

Journal of Psychiatric Research

Volumn 50, Issue 1, 2014, Pages 42-50

  Able, Jessica A ^a   Liu, Yanhong ^a   Jandacek, Ronald ^a   Rider, Therese ^a   Tso, Patrick ^a   McNamara, Robert K ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Docosahexaenoic acid; Fluoxetine; Forced swim test; Omega 3 fatty acid; Serotonin transporter; Tryptophan hydroxylase 2

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; DOCOSAHEXAENOIC ACID; DRINKING WATER; LINOLENIC ACID; MESSENGER RNA; NORADRENALIN; OMEGA 3 FATTY ACID; SEROTONIN; SEROTONIN 1A RECEPTOR; TYROSINE 3 MONOOXYGENASE;

ADOLESCENT DEVELOPMENT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CLIMBING; CONTROLLED STUDY; FORCED SWIM TEST; IMMOBILITY; LIPID COMPOSITION; MALE; MESENCEPHALON; NEUROCHEMISTRY; NEUROTRANSMISSION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SWIMMING;

5-HT(1A) AUTORECEPTOR; ALPHA(2A) ADRENERGIC RECEPTOR; DOCOSAHEXAENOIC ACID; FLUOXETINE; FORCED SWIM TEST; OMEGA-3 FATTY ACID; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE-2;

ALPHA-LINOLENIC ACID; ANIMALS; BODY WEIGHT; BRAIN; DIET; FATTY ACIDS, OMEGA-3; FLUOXETINE; MALE; MOTOR ACTIVITY; RANDOM ALLOCATION; RATS; RATS, LONG-EVANS; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, ADRENERGIC, ALPHA-2; RNA, MESSENGER; SEROTONIN UPTAKE INHIBITORS; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 84892517509     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2013.11.008     Document Type: Article

References (71)

1. Amsterdam J.D., Fawcett J., Quitkin F.M., Reimherr F.W., Rosenbaum J.F., Michelson D., et al. Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study. Am J Psychiatry 1997, 154:963-969.
2. Arango V., Underwood M.D., Boldrini M., Tamir H., Kassir S.A., Hsiung S., et al. Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 2001, 25:892-903.
3. Arango V., Underwood M.D., Gubbi A.V., Mann J.J. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res 1995, 688:121-133.
4. Assies J., Pouwer F., Lok A., Mocking R.J., Bockting C.L., Visser I., et al. Plasma and erythrocyte fatty acid patterns in patients with recurrent depression: a matched case-control study. PLoS One 2010, 5(5):e10635.
5. Barbon A., Orlandi C., La Via L., Caracciolo L., Tardito D., Musazzi L., et al. Antidepressant treatments change 5-HT2C receptor mRNA expression in rat prefrontal/frontal cortex and hippocampus. Neuropsychobiology 2011, 63:160-168.
6. Beyer C.E., Lin Q., Rosenzweig-Lipson S., Schechter L.E. Alpha 2A-adrenoceptors enhance the serotonergic effects of fluoxetine. Eur J Pharmacol 2006, 539(3):164-167.
7. Boldrini M., Underwood M.D., Mann J.J., Arango V. Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides. JPsychiatr Res 2008, 42:433-442.
8. Carlezon W.A., Mague S.D., Parow A.M., Stoll A.L., Cohen B.M., Renshaw P.F. Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats. Biol Psychiatry 2005, 57:343-350.
9. Celada P., Puig M.V., Casanovas J.M., Guillazo G., Artigas F. Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: involvement of serotonin-1A, GABA(A), and glutamate receptors. JNeurosci 2001, 21:9917-9929.
10. Chalon S., Delion-Vancassel S., Belzung C., Guilloteau D., Leguisquet A.M., Besnard J.C., et al. Dietary fish oil affects monoaminergic neurotransmission and behavior in rats. JNutr 1998, 128:2512-2519.
11. Chalon S. Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids 2006, 75:259-269.
12. Cheetham S.C., Crompton M.R., Katona C.L., Horton R.W. Brain 5-HT1 binding sites in depressed suicides. Psychopharmacology (Berl) 1990, 102:544-548.
13. Chiu C.C., Huang S.Y., Su K.P., Lu M.L., Huang M.C., Chen C.C., et al. Polyunsaturated fatty acid deficit in patients with bipolar mania. Eur Neuropsychopharmacol 2003, 13:99-103.
14. Conklin S.M., Runyan C.A., Leonard S., Reddy R.D., Muldoon M.F., Yao J.K. Age-related changes of n-3 and n-6 polyunsaturated fatty acids in the anterior cingulate cortex of individuals with major depressive disorder. Prostaglandins Leukot Essent Fatty Acids 2010, 82:111-119.
15. Cryan J.F., Page M.E., Lucki I. Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Psychopharmacology (Berl) 2005, 182:335-344.
16. Cryan J.F., Page M.E., Lucki I. Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test. Eur J Pharmacol 2002, 436:197-205.
17. Delion S., Chalon S., Guilloteau D., Besnard J.C., Durand G. alpha-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex. JNeurochem 1996, 66:1582-1591.
18. DeMar J.C., Ma K., Bell J.M., Igarashi M., Greenstein D., Rapoport S.I. One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats. JLipid Res 2006, 47:172-180.
19. Detke M.J., Wieland S., Lucki I. Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists. Psychopharmacology (Berl) 1995, 119:47-54.
20. Detke M.J., Johnson J., Lucki I. Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Exp Clin Psychopharmacol 1997, 5:107-112.
21. Dhir A., Kulkarni S.K. Effect of addition of yohimbine (alpha-2-receptor antagonist) to the antidepressant activity of fluoxetine or venlafaxine in the mouse forced swim test. Pharmacology 2007, 80:239-243.
22. Drossopoulou G., Antoniou K., Kitraki E., Papathanasiou G., Papalexi E., Dalla C., et al. Sex differences in behavioral, neurochemical and neuroendocrine effects induced by the forced swim test in rats. Neuroscience 2004, 126:849-857.
23. Dygalo N.N., Shishkina G.T., Kalinina T.S., Yudina A.M., Ovchinnikova E.S. Effect of repeated treatment with fluoxetine on tryptophan hydroxylase-2 gene expression in the rat brainstem. Pharmacol Biochem Behav 2006, 85:220-227.
24. Edwards R., Peet M., Shay J., Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. JAffect Disord 1998, 48:149-155.
25. Faedda G.L., Baldessarini R.J., Glovinsky I.P., Austin N.B. Treatment-emergent mania in pediatric bipolar disorder: a retrospective case review. JAffect Disord 1998, 82:149-158.
26. Gertsik L., Poland R.E., Bresee C., Rapaport M.H. Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder. JClin Psychopharmacol 2012, 32:61-64.
27. Gobert A., Rivet J.M., Cistarelli L., Melon C., Millan M.J. Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats. JNeurochem 1997, 69:2616-2619.
28. Haddjeri N., Lavoie N., Blier P. Electrophysiological evidence for the tonic activation of 5-HT(1A) autoreceptors in the rat dorsal raphe nucleus. Neuropsychopharmacology 2004, 29:1800-1806.
29. Hajós-Korcsok E., McQuade R., Sharp T. Influence of 5-HT1A receptors on central noradrenergic activity: microdialysis studies using (+/-)-MDL 73005EF and its enantiomers. Neuropharmacology 1999, 38:299-306.
30. Hajós-Korcsok E., Sharp T. 8-OH-DPAT-induced release of hippocampal noradrenaline invivo: evidence for a role of both 5-HT1A and dopamine D1 receptors. Eur J Pharmacol 1996, 314:285-291.
31. Hammad T.A., Laughren T., Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 2006, 63:332-339.
32. Hemby S.E., Lucki I., Gatto G., Singh A., Thornley C., Matasi J., et al. Potential antidepressant effects of novel tropane compounds, selective for serotonin or dopamine transporters. JPharmacol Exp Ther 1997, 282:727-733.
33. Huan M., Hamazaki K., Sun Y., Itomura M., Liu H., Kang W., et al. Suicide attempt and n-3 fatty acid levels in red blood cells: a case control study in China. Biol Psychiatry 2004, 56:490-496.
34. Huang S.Y., Yang H.T., Chiu C.C., Pariante C.M., Su K.P. Omega-3 fatty acids on the forced-swimming test. JPsychiatr Res 2008, 42:58-63.
35. Invernizzi R., Bramante M., Samanin R. Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output: role of presynaptic 5-HT1A receptors. Eur J Pharmacol 1994, 260:243-246.
36. Jazayeri S., Tehrani-Doost M., Keshavarz S.A., Hosseini M., Djazayery A., Amini H., et al. Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder. Aust N Z J Psychiatry 2008, 42:192-198.
37. Klimek V., Stockmeier C., Overholser J., Meltzer H.Y., Kalka S., Dilley G., et al. Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. JNeurosci 1997, 17:8451-8458.
38. Kodas E., Galineau L., Bodard S., Vancassel S., Guilloteau D., Besnard J.C., et al. Serotoninergic neurotransmission is affected by n-3 polyunsaturated fatty acids in the rat. JNeurochem 2004, 89:695-702.
39. Laino C.H., Fonseca C., Sterin-Speziale N., Slobodianik N., Reinés A. Potentiation of omega-3 fatty acid antidepressant-like effects with low non-antidepressant doses of fluoxetine and mirtazapine. Eur J Pharmacol 2010, 648:117-126.
40. Lakhwani L., Tongia S.K., Pal V.S., Agrawal R.P., Nyati P., Phadnis P. Omega-3 fatty acids have antidepressant activity in forced swimming test in Wistar rats. Acta Pol Pharm 2007, 64:271-276.
41. Le Poul E., Boni C., Hanoun N., Laporte A.M., Laaris N., Chauveau J., et al. Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology 2000, 39:110-122.
42. Le Poul E., Laaris N., Doucet E., Laporte A.M., Hamon M., Lanfumey L. Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn Schmiedebergs Arch Pharmacol 1995, 352:141-148.
43. Lemonde S., Turecki G., Bakish D., Du L., Hrdina P.D., Bown C.D., et al. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. JNeurosci 2003, 23:8788-8799.
44. Lemonde S., Du L., Bakish D., Hrdina P., Albert P.R. Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response. Int J Neuropsychopharmacol 2004, 7:501-506.
45. Lin P.Y., Huang S.Y., Su K.P. Ameta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry 2010, 68:140-144.
46. López-Figueroa A.L., Norton C.S., López-Figueroa M.O., Armellini-Dodel D., Burke S., Akil H., et al. Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia. Biol Psychiatry 2004, 55:225-233.
47. Mathieu G., Denis S., Lavialle M., Vancassel S. Synergistic effects of stress and omega-3 fatty acid deprivation on emotional response and brain lipid composition in adult rats. Prostaglandins Leukot Essent Fatty Acids 2008, 78:391-401.
48. Mathieu G., Oualian C., Denis I., Lavialle M., Gisquet-Verrier P., Vancassel S. Dietary n-3 polyunsaturated fatty acid deprivation together with early maternal separation increases anxiety and vulnerability to stress in adult rats. Prostaglandins Leukot Essent Fatty Acids 2011, 85:129-136.
49. Matsubara S., Arora R.C., Meltzer H.Y. Serotonergic measures in suicide brain: 5-HT1A binding sites in frontal cortex of suicide victims. JNeural Transm Gen Sect 1991, 85:181-194.
50. McNamara R.K., Hahn C.-G., Jandacek R., Rider T., Tso P., Stanford K., et al. Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biol Psychiatry 2007, 62:17-24.
51. McNamara R.K., Jandacek R., Rider T., Tso P., Stanford K., Hahn C.-G., et al. Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder. Psychiatric Res. 2008, 160:285-299.
52. McNamara R.K., Able J.A., Liu Y., Jandacek R., Rider T., Tso P., et al. Omega-3 fatty acid deficiency during perinatal development increases serotonin turnover in the prefrontal cortex and decreases midbrain tryptophan hydroxylase-2 expression in adult female rats: dissociation from estrogenic effects. JPsychiatr Res 2009, 43:656-663.
53. McNamara R.K., Jandacek R., Rider T., Tso P., Dwivedi Y., Pandey G.N. Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder. JAffect Disord 2010, 126:303-311.
54. McNamara R.K., Jandacek R., Tso P., Dwivedi Y., Ren X., Pandey G.N. Lower docosahexaenoic acid concentrations in the postmortem prefrontal cortex of adult depressed suicide victims compared with controls without cardiovascular disease. JPsychiatr Res 2013, 47:1187-1191.
55. Ordway G.A., Widdowson P.S., Smith K.S., Halaris A. Agonist binding to alpha 2-adrenoceptors is elevated in the locus coeruleus from victims of suicide. JNeurochem 1994, 63:617-624.
56. Page M.E., Detke M.J., Dalvi A., Kirby L.G., Lucki I. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology (Berl) 1999, 147:162-167.
57. Peet M., Murphy B., Shay J., Horrobin D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 1998, 43:315-319.
58. Peet M., Horrobin D.F. Adose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 2002, 59:913-919.
59. Rénéric J.P., Bouvard M., Stinus L. Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA/5-HT reuptake inhibition in the rat forced swimming test. Neuropsychopharmacology 2001, 24:379-390.
60. Shishkina G.T., Kalinina T.S., Dygalo N.N. Up-regulation of tryptophan hydroxylase-2 mRNA in the rat brain by chronic fluoxetine treatment correlates with its antidepressant effect. Neuroscience 2007, 150:404-412.
61. Singh A., Lucki I. Antidepressant-like activity of compounds with varying efficacy at 5-HT1A receptors. Neuropharmacology 1993, 32:331-340.
62. Sprouse J.S., Aghajanian G.K. (-)-Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists. Eur J Pharmacol 1986, 128:295-298.
63. Spurlock G., Buckland P., O'Donovan M., McGuffin P. Lack of effect of antidepressant drugs on the levels of mRNAs encoding serotonergic receptors, synthetic enzymes and 5HT transporter. Neuropharmacology 1994, 33:433-440.
64. Stockmeier C.A., Dilley G.E., Shapiro L.A., Overholser J.C., Thompson P.A., Meltzer H.Y. Serotonin receptors in suicide victims with major depression. Neuropsychopharmacology 1997, 16:162-173.
65. Stockmeier C.A., Shapiro L.A., Dilley G.E., Kolli T.N., Friedman L., Rajkowska G. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. JNeurosci 1998, 18:7394-7401.
66. Strawn J.R., Adler C.M., McNamara R.K., Welge J.A., Bitter S.M., Mills N., et al. Antidepressant tolerability in anxious and depressed youth at high-risk for bipolar disorder: a prospective naturalistic treatment study. Bipolar Disord 2013, [in press].
67. Sublette M.E., Hibbeln J.R., Galfalvy H., Oquendo M.A., Mann J.J. Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. Am J Psychiatry 2006, 163:1100-1102.
68. Swann A.C. Mechanisms of impulsivity in bipolar disorder and related illness. Epidemiol Psichiatr Soc 2010, 19:120-130.
69. Tatebayashi Y., Nihonmatsu-Kikuchi N., Hayashi Y., Yu X., Soma M., Ikeda K. Abnormal fatty acid composition in the frontopolar cortex of patients with affective disorders. Transl Psychiatry 2012, 2:e204.
70. Vancassel S., Leman S., Hanonick L., Denis S., Roger J., Nollet M., et al. n-3 polyunsaturated fatty acid supplementation reverses stress-induced modifications on brain monoamine levels in mice. JLipid Res 2008, 49:340-348.
71. Vines A., Delattre A.M., Lima M.M., Rodrigues L.S., Suchecki D., Machado R.B., et al. The role of 5-HT1A receptors in fish oil-mediated increased BDNF expression in the rat hippocampus and cortex: a possible antidepressant mechanism. Neuropharmacology 2012, 62:184-191.